CN100455290C - 新的幽门螺杆菌受体及其用途 - Google Patents

新的幽门螺杆菌受体及其用途 Download PDF

Info

Publication number
CN100455290C
CN100455290C CNB028057538A CN02805753A CN100455290C CN 100455290 C CN100455290 C CN 100455290C CN B028057538 A CNB028057538 A CN B028057538A CN 02805753 A CN02805753 A CN 02805753A CN 100455290 C CN100455290 C CN 100455290C
Authority
CN
China
Prior art keywords
binding
substance
helicobacter pylori
oligosaccharide
pylori
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028057538A
Other languages
English (en)
Chinese (zh)
Other versions
CN1525862A (zh
Inventor
哈利那·米勒-波德拉扎
苏珊·特尼伯格
乔纳斯·安格斯特罗姆
卡尔-安德斯·卡尔森
贾里·纳图南
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotie Therapies Corp
Original Assignee
Biotie Therapies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotie Therapies Corp filed Critical Biotie Therapies Corp
Publication of CN1525862A publication Critical patent/CN1525862A/zh
Application granted granted Critical
Publication of CN100455290C publication Critical patent/CN100455290C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CNB028057538A 2001-01-19 2002-01-18 新的幽门螺杆菌受体及其用途 Expired - Fee Related CN100455290C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20010118 2001-01-19
FI20010118A FI20010118L (fi) 2001-01-19 2001-01-19 Uudet helicobacter pylori reseptorit ja niiden käyttö

Publications (2)

Publication Number Publication Date
CN1525862A CN1525862A (zh) 2004-09-01
CN100455290C true CN100455290C (zh) 2009-01-28

Family

ID=8560066

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028057538A Expired - Fee Related CN100455290C (zh) 2001-01-19 2002-01-18 新的幽门螺杆菌受体及其用途

Country Status (19)

Country Link
US (1) US20040096465A1 (enExample)
EP (1) EP1359922A1 (enExample)
JP (1) JP2004519459A (enExample)
KR (1) KR100886777B1 (enExample)
CN (1) CN100455290C (enExample)
AU (1) AU2002229792B2 (enExample)
CA (1) CA2434350A1 (enExample)
CZ (1) CZ20031914A3 (enExample)
EE (1) EE200300339A (enExample)
FI (1) FI20010118L (enExample)
HU (1) HUP0302790A3 (enExample)
IL (1) IL156992A0 (enExample)
NO (1) NO20033270L (enExample)
NZ (1) NZ526906A (enExample)
PL (1) PL363617A1 (enExample)
RU (1) RU2306140C2 (enExample)
SK (1) SK10042003A3 (enExample)
WO (1) WO2002056893A1 (enExample)
ZA (1) ZA200305155B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof
FI20011671A7 (fi) 2001-08-20 2003-02-21 Carbion Oy Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
US20050220819A1 (en) * 2002-01-18 2005-10-06 Biotie Therapies Oyj Novel binding epitopes for helicobacter pylori and use thereof
EP1531832B1 (en) * 2002-06-28 2009-04-15 Glykos Finland Oy Therapeutic compositions for use in prophylaxis or treatment of diarrheas
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
WO2004065400A1 (en) * 2003-01-20 2004-08-05 Glykos Finland Oy Novel binding epitopes for helicobacter pylori and use thereof
JP5035787B2 (ja) * 2005-10-04 2012-09-26 焼津水産化学工業株式会社 α−１、４結合型Ｎ−アセチルグルコサミン含有Ｏ−グリカン型糖鎖の分泌促進剤並びにこれを含有するヘリコバクターピロリ菌を原因とする病態の治療予防剤
JP5140246B2 (ja) * 2006-03-15 2013-02-06 公益財団法人野口研究所 Ｎ−アセチルグルコサミンの誘導体を含有するピロリ菌増殖抑制剤
JP5014018B2 (ja) * 2006-10-18 2012-08-29 旭化成ケミカルズ株式会社 ピロリ菌の抑制剤または静菌剤
US8075674B2 (en) 2006-11-30 2011-12-13 Donaldson Company, Inc. Filter apparatus with pulse cleaning and methods for pulse cleaning filters
US20100233198A1 (en) * 2007-11-08 2010-09-16 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
AU2013237497B2 (en) * 2012-03-19 2016-05-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Carbohydrate-glycolipid conjugate vaccines
AU2013338153B2 (en) * 2012-10-29 2018-06-21 The Board Of Trustees Of The University Of Arkansas Novel mucosal adjuvants and delivery systems
CN112023037A (zh) * 2020-09-09 2020-12-04 四川大学 一种聚糖在制备对Hp感染的预防和治疗产品中的应用、产品及制备方法
CN112285338B (zh) * 2020-10-20 2023-04-28 四川大学华西医院 一种copd诊断试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675392A (en) * 1982-06-23 1987-06-23 Svenska Sockerfabriks Ab Glycosides
CN1022687C (zh) * 1985-01-14 1993-11-10 斯姆比克姆公司 制备糖苷衍生物的方法
US5386027A (en) * 1988-08-01 1995-01-31 The United States Of America As Represented By The Department Of Health & Human Services Carbohydrate receptor for bacteria and method for use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
KR960022566A (ko) * 1994-12-30 1996-07-18 김충환 신규한 아미노올리고당 유도체 및 그의 제조방법
US5736533A (en) * 1995-06-07 1998-04-07 Neose Technologies, Inc. Bacterial inhibition with an oligosaccharide compound
JPH1045602A (ja) * 1996-07-31 1998-02-17 Motoyasu Murakami ヘリコバクター・ピロリ接着阻害剤またはインターロイキン−８産生阻害剤
SE9904581D0 (sv) * 1999-12-15 1999-12-15 A & Science Invest Ab A novel helicobacter pylori-binding substance and use thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675392A (en) * 1982-06-23 1987-06-23 Svenska Sockerfabriks Ab Glycosides
CN1022687C (zh) * 1985-01-14 1993-11-10 斯姆比克姆公司 制备糖苷衍生物的方法
US5386027A (en) * 1988-08-01 1995-01-31 The United States Of America As Represented By The Department Of Health & Human Services Carbohydrate receptor for bacteria and method for use thereof

Also Published As

Publication number Publication date
KR20040018329A (ko) 2004-03-03
FI20010118A7 (fi) 2002-07-20
ZA200305155B (en) 2004-07-19
US20040096465A1 (en) 2004-05-20
AU2002229792B2 (en) 2007-08-16
CA2434350A1 (en) 2002-07-25
HUP0302790A2 (hu) 2003-11-28
CZ20031914A3 (cs) 2004-04-14
FI20010118L (fi) 2002-07-20
CN1525862A (zh) 2004-09-01
PL363617A1 (pl) 2004-11-29
JP2004519459A (ja) 2004-07-02
HUP0302790A3 (en) 2010-01-28
RU2306140C2 (ru) 2007-09-20
FI20010118A0 (fi) 2001-01-19
EP1359922A1 (en) 2003-11-12
SK10042003A3 (sk) 2003-11-04
NO20033270D0 (no) 2003-07-18
NZ526906A (en) 2005-03-24
IL156992A0 (en) 2004-02-08
KR100886777B1 (ko) 2009-03-04
RU2003125370A (ru) 2005-02-10
WO2002056893A1 (en) 2002-07-25
WO2002056893A8 (en) 2003-11-13
EE200300339A (et) 2003-10-15
NO20033270L (no) 2003-09-19

Similar Documents

Publication Publication Date Title
EP2272522B1 (en) Therapeutic compositions for use in prophylaxis or treatment of diarrheas
EP1411952B1 (en) Use of at least one glycoinhibitor substance against infectious diseases
CN100455290C (zh) 新的幽门螺杆菌受体及其用途
US20040180850A1 (en) Methods and compositions for treatment of gastric diseases
AU2002229792A1 (en) Novel receptors for Helicobacter pylori and use thereof
AU783876B2 (en) Novel helicobacter pylori-binding substances and use thereof
US20060122148A1 (en) High affinity receptors for helicobacter pylori and use thereof
US20050220819A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
WO2004065400A1 (en) Novel binding epitopes for helicobacter pylori and use thereof
Natunen Use of at least one glycoinhibitor substance

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090128

Termination date: 20110118